< Back to previous page
Researcher
Raffaella Ravinetto
- Keywords:research ethics, quality of medicines, access to medicines, B740-pharmacy, equity, pharmaceutical policies, public health
- Disciplines:Public health sciences not elsewhere classified, Clinical trials, Health and community services
Affiliations
- Pharmaceutical Public Health (Research unit)
Member
From1 Jul 2023 → Today - Department of Public Health (Department)
Responsible
From1 Nov 2006 → Today - Pharmaceutical Public Health (Research unit)
Responsible
From30 Jun 2023 → 12 Dec 2023 - Equity and Health (Research unit)
Member
From17 May 2018 → 22 Aug 2023 - Equity and Health (Research unit)
Member
From17 May 2018 → 31 May 2023 - Clinical Trial Centre (Research unit)
Member
From1 Nov 2006 → 9 Nov 2016 - Clinical Trial Centre (Research unit)
Member
From1 Nov 2006 → 16 Apr 2015
Projects
1 - 8 of 8
- Equitable access to quality-assured health products. Trends, challenges and barriers for non-communicable diseases, taking the example of diabetes related medicine and technologies.From15 Oct 2025 → Today
- Barriers and solutions to accessing essential breast cancer medicines in low resource settings – a mixed-methods study to investigate the pharmaceutical, economic, and policy challenges within the Zimbabwean contextFrom6 Jun 2025 → Today
- Safety Monitoring of Drug-Resistant Tuberculosis Medicines in Indonesia Using Pharmacovigilance FrameworkFrom6 Jun 2025 → Today
- Pharmaceutical systems resilience and access to essential medicines in conflict-affected regions: The case of antibiotics in Northern SyriaFrom1 Oct 2024 → TodayFunding: FWO fellowships
- A Directed Search for a Treponema pallidum Antigen TestFrom1 Jul 2013 → 28 Feb 2019
- Care package for treatment and control of visceral leishmaniasis in East AfricaFrom1 Jan 2013 → 31 Dec 2016
- Towards strenghtening of the West African Node of excellence for TB, AIDS & MalariaFrom27 Oct 2011 → 31 Aug 2014
- Impact of the clinical trials on the health behaviours of the communities and the quality of the health services in West and East AfricaFrom6 Jun 2011 → 6 Jun 2013
Publications
1 - 10 of 134
- Access to essential medicines for noncommunicable diseases during conflicts: The case cardiovascular diseases, diabetes and epilepsy in Northern Syria(2025)Published in: PLoS Global Public HealthISSN: 2767-3375Issue: 12Volume: 5Pages: e0004744
- Irrational medicine use and its associated factors in conflict-affected areas in Mali: a cross-sectional study(2025)Published in: Global Health ActionISSN: 1654-9880Issue: 1Volume: 18
- Assessing patterns of authorship of low- and middle-income countries in global commercial clinical trials in oncology(2025)Published in: Globalization and HealthISSN: 1744-8603
- Availability of essential medicines in 14 remaining health facilities in Gaza(2025)Published in: LancetISSN: 0140-6736Issue: 10511Volume: 406Pages: 1465-1467
- Assessing the performance of local pharmaceutical systems: An analytical approach to improve access to medicine(2025)Published in: The journal of medicine accessISSN: 2755-0834Volume: 9
- Correspondence on "Changes in memory and cognition during the SARS-CoV-2 human challenge study"(2025)Published in: EClinicalMedicineISSN: 2589-5370Volume: 81
- Dispensing of medicines for asthma and chronic obstructive pulmonary disease through the government health insurance in Syria: a retrospective analysis(2025)Published in: Global Health ActionISSN: 1654-9880Volume: 18
- "We have to amplify what we saw at EBOVAC" - Assessing participant perceptions, attitudes, and acceptability of an ancillary care policy in an Ebola vaccine trial in the Democratic Republic of the Congo: a mixed methods study(2025)Published in: PLoS ONEISSN: 1932-6203Issue: 6Volume: 20Pages: e0325435
- Sanctions and the right to health in post-Assad Syria(2025)Published in: LancetISSN: 0140-6736Issue: 10473Volume: 405Pages: 119-120
- Healthcare-associated bloodstream infections caused by bacterial and fungal contamination of intravenous fluids and medicines in healthcare facilities in low- and middle-income countries: a scoping review(2025)Published in: Antimicrobial Resistance and Infection ControlISSN: 2047-2994Issue: 1Volume: 14